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ABSTRACT
Objectives The objective of this study was to develop an
estimate of a radio frequency (RF) dose as the amount of
mobile phone RF energy absorbed at the location of
a brain tumour, for use in the Interphone Epidemiological
Study.
Methods We systematically evaluated and quantiﬁed all
the main parameters thought to inﬂuence the amount of
speciﬁc RF energy absorbed in the brain from mobile
telephone use. For this, we identiﬁed the likely important
determinants of RF speciﬁc energy absorption rate during
protocol and questionnaire design, we collected
information from study subjects, network operators and
laboratories involved in speciﬁc energy absorption rate
measurements and we studied potential modiﬁers of
phone output through the use of software-modiﬁed
phones. Data collected were analysed to assess the
relative importance of the different factors, leading to the
development of an algorithm to evaluate the total
cumulative speciﬁc RF energy (in joules per kilogram), or
dose, absorbed at a particular location in the brain. This
algorithm was applied to Interphone Study subjects in
ﬁve countries.
Results The main determinants of total cumulative
speciﬁc RF energy from mobile phones were
communication system and frequency band, location in
the brain and amount and duration of mobile phone use.
Though there was substantial agreement between
categorisation of subjects by cumulative speciﬁc RF
energy and cumulative call time, misclassiﬁcation was
non-negligible, particularly at higher frequency bands.
Factors such as adaptive power control (except in Code
Division Multiple Access networks), discontinuous
transmission and conditions of phone use were found to
have a relatively minor inﬂuence on total cumulative
speciﬁc RF energy.
Conclusions While amount and duration of use are
important determinants of RF dose in the brain, their
impact can be substantially modiﬁed by communication
system, frequency band and location in the brain. It is
important to take these into account in analyses of risk of
brain tumours from RF exposure from mobile phones.
INTRODUCTION
The multinational epidemiological study
Interphone
1 was conducted to evaluate the possible
relationship between risk of brain, acoustic nerve
and parotid gland tumours and radio frequency
(RF) exposure from mobile phones. Most
epidemiological papers to date have evaluated risk
only in relation to reported mobile phone use.
2e21
The relation between mobile phone use and RF
dose (expressed as energy absorption) at the
location of the tumour is complex, however,
particularly since dose is localised. The Japanese
Interphone Study
20 developed dose indices taking
localised absorption into account by multiplying
phone duration by spatial maximum speciﬁc energy
absorption rate (SAR) in the tumour region. SAR,
in watts per kilogram, represents absorbed power
per unit mass of tissue, a widely used metric of RF
dose rate.
22 23
Many parameters can, however, inﬂuence
amount and distribution of RF dose in the
brain,
20 24 25 including telephone type, network
characteristics, and amount and conditions of
phone use.
This paper presents an algorithm, developed
within Interphone, to account for these parameters
for dose estimation in epidemiological studies and
illustrates its application on study subjects from
ﬁve Interphone countries (Australia, Canada,
France, Israel and New Zealand).
METHODS
Interphone is a collaborative caseecontrol study
conducted in 13 countries (Australia, Canada,
Denmark, Finland, France, Germany, Israel, Italy,
Japan, New Zealand, Norway, Sweden and the
UK). Study methods and results of analyses of
brain tumour risk related to mobile phone use have
been published.
1 61 11 21 4 e16 18e21
Subjects were interviewed using a questionnaire,
including a mobile phone use calendar, structured
according to factors that could change patterns of
phone use and output power. Hundreds of pictures
of mobile phones were compiled to assist subjects
< Additional materials are
published online only. To view
these ﬁles please visit the journal
online (http://oem.bmj.com).
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What this paper adds
< Epidemiological studies of brain tumours in
relation to mobile phone use have mainly
analysed risk in relation to amount and duration
of use of mobile phones.
< While these factors are important determinants
of the amount of radio frequency energy in the
brain, our results suggest that their impact can
be substantially modiﬁed by communication
system, frequency band and tumour location.
< It is therefore important to take these into
account in analyses of risk of brain tumours in
relation to radio frequency exposure in Inter-
phone and future caseecontrol and cohort
studies.
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Original articlein identifying models used. Phone use for each subject was
reported by period of use for each phone; if use changed,
multiple periods were reported. For each period, questions were
completed concerning network operator and duration and
number of calls. Information on laterality, call environment and
use of hands-free devices was collected. Information was also
collected about Digital Enhanced Cordless Telecommunications
(DECT) telephones. As use was limited among study subjects
and because both peak and mean output are lower for mobile
phones in the study, they were not included in the RF dose
estimation.
An important goal was to collect all information necessary for
estimation of the subject’s RF dose (ﬁgure 1):
< Responses of individual subjects to the questionnaire (above);
< Diagnostic images and report for cases, which permitted
neuroradiologists to localise the tumour and its estimated
centre on a 3-dimensional (3D) grid, the Gridmaster,
26 so that
RF dose at that location could be evaluated;
< Historical information on communication technologies and
network characteristics obtained by questionnaire from
network operators and from published documents and
standards. The questionnaire concerned history of different
communication systems and frequency bands, enablement of
adaptive power control (APC), discontinuous transmission
(DTX) and percentage of trafﬁc in each band or system
(where multiple bands/systems were in operation);
< A database of SAR spatial distributions in the head, based on
phantom dosimetric measurements made in France Telecom
RD laboratory and Japanese Telecom Engineering Center
27;
< A compilation of published SARmax values (SAR measured
with phone emitting at maximum power), averaged over 1 or
10 g of tissue, depending on applicable standards, for a large
number of phones commercialised during and before the
study;
< A phone output power database, derived from the use in most
Interphone countries of software-modiﬁed Global System for
Mobile (GSM) phones (SMPs), which stored usage, power
and frequency data.
28 Some measurements were also made in
non-GSM networks.
Mobile communication systems
Mobile telephone use started in most Interphone countries
between the mid- and late 1980’s. Communication systems are
often categorised into generations, with early analogue systems
classiﬁed as ﬁrst generation, early digital systems as second
generation and recent digital systems with enhanced data
capability as third generation. Characteristics of communication
systems, including analogue/digital technology, frequency
band, emitted power and enablement of APC, are elements that
may affect RF dose from mobile phones. The phone systems
relevant for Interphone countries, together with their history
and characteristics, are discussed in online appendix 1.
Elements of the RF dose algorithm
SAR distributions from mobile phones
Hundreds of different phone models were reported by Interphone
Study subjects. It was essential to determine whether brain
radiation patterns differ between phones and, if so, to develop
a method for assessing SAR distribution from different models.
Computer simulations and experiments using phantoms
(representing a head ﬁlled with homogeneous liquid) are the
main dosimetric approaches used to produce an SAR distribution
from a mobile phone, emitting in a speciﬁc frequency band, held
in a speciﬁc position and radiating a speciﬁc power. Work
involved is considerable, and it was not practical to conduct such
detailed dosimetry for every phone model used.
Results of SAR dosimetric measurements made in two
broadly used standard phantoms (Speciﬁc Anthropomorphic
Mannequin
22 and Generic Twin
29 30) were therefore analysed to
derive 3D SAR distributions in the brain for mobile phones used
by the study subjects and assign absolute levels of dose in the
most exposed brain area. The approach, shown in online
appendix ﬁgure 1, is detailed below.
Identiﬁcation of phone classes
The aim was to identify phone classes producing distinct spatial
distributions in the brain into which phones used historically by
study subjects could be classiﬁed. Analyses of SAR spatial
distribution were conducted using dosimetric databases from
France and Japan on over 100 phone models from different
countries and time periods,
27 and clusters of SAR distributions
were sought in relation to external phone features and commu-
nication system. The method is described in detail elsewhere.
31
3D distribution of SAR in Gridmaster
Each phone in the measurement database had ﬁnely sampled
(1 mm) data only in the vicinity of the spatial peak SAR (close
to the phone) and no measurement throughout large portions
of the head (online appendix ﬁgure 2). A method was developed
to estimate average SAR in each cube of the 1 cm
3 Gridmaster
so that SAR at the location of each tumour could be derived
Figure 1 Combining the information collected in the Interphone study
into an RF dose estimate
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Original article(see
32 for details). For each cube in the vicinity of the spatial
peak, the ﬁnely sampled SAR measurements were averaged. The
parameter of the exponential decay function inside the brain
was estimated and average SAR in 1 cm
3 extrapolated to the
entire Gridmaster. Validation of the method was performed
experimentally and numerically.
32
3D SAR distributions for each phone class
The spatial SAR distribution in a phone class was obtained by
deriving the average, median and range of SAR values in each
cube from all phones in the class. The relative average SAR value
was computed in each Gridmaster cube as the ratio of its average
SAR to the average in the cube with the highest SAR (generally
located in the outer layer of the grid near the ear). Detailed
methods have been published.
27
Output power levels
A mobile phone’s RF emissions are directly proportional to its
output power, which may vary substantially between different
networks (depending on infrastructure at a given time,
communication system, frequency band, enablement of
different transmission protocols, such as DTX) and phone use
circumstances (moving/stationary, urban/rural settings) due to
power control technologies, such as APC. Determinants of
output power were studied in volunteers in 12 countries who
used GSM SMPs for approximately 1 month each. Detailed
methods and results have been published.
28 The SMPs recorded
frequency band and output power at ﬁxed sampling intervals
throughout calls. Questionnaires provided information on
typical circumstances of the volunteer’s phone use. Regression
models were used to analyse inﬂuence of possible explanatory
variables on output power of the phones.
Phone-speciﬁc SAR values
The SARmax of phones varies considerably with phone model
and was thought to possibly relate to marketing period.
Reported SARmax values for particular phone models were
compiled from all accessible sources, including manufacturers’
websites, formal comparison studies and the ‘grey’ literature
(including consumer magazines and websites). This dosimetry
information was compiled into a database, including informa-
tion on phone characteristics, measuring laboratory, phantoms
and measurement protocols.
Statistical analyses
Descriptive analyses of the resulting dose estimate were
conducted, producing standard summary statistics. Agreement
between classiﬁcation of subjects by categories of dose and of
mobile phone history was evaluated using a weighted k
statistic.
33 Analysis of variance was conducted to evaluate the
relative importance of different factors in dose estimation.
RESULTS
SAR distributions from mobile phones
Identiﬁcation of phone classes
Analysis showed some clustering of phone types related to the
combination of phone position and shape.
31 The position in
which phones are held varies between individuals and, for the
same individual, during use and with different phones. Classi-
ﬁcations of SAR distributions using phone position therefore
cannot be used in epidemiological studies.
Frequency is known to be inversely related to penetration
depth of radiation.
34 Phones were therefore classiﬁed by band as
follows: 800e900, 1500 and 1800e1900 MHz. No measurement
and limited simulations were available on 450 MHz phones, and
only 14 subjects in the ﬁve countries reported ever using them;
they were therefore included with 800e900 MHz phones.
Average spatial SAR distribution for each phone class
From each phone measured, 3D SAR distributions were esti-
mated in the Gridmaster and, for each phone class, the average
SAR distribution was derived. Figure 2 shows average SAR
distributions in the brain at 800e900 and 1800 MHz.
Most of the SAR in the brain (97%e99% depending on
frequency band) appeared to be absorbed in the hemisphere on
the side where the phone is used, mainly (50%e60%) in the
temporal lobe. The average relative SAR decreased rapidly with
depth, particularly at higher frequencies (ﬁgure 2). The SAR
distribution appeared similar across phone models, between
older and newer phones, and between phones with different
antenna types and positions.
27
Output power levels
Inﬂuence of APC
In GSM phones, before APC was introduced in the early 1990s,
phones worked to maximum power. The SMP study conducted
between 2001 and 2005 with four GSM models, and over 63000
calls made by 516 subjects in 12 countries, showed that, on
average, APC reduced power to around 50% of the maximum
power levels in both 900 and 1800 MHz frequency bands.
28
Results from this and other studies
35e40 are broadly consistent
in the period 1999e2005 for GSM networks.
For any historical dose index, however, extrapolation in time
is necessary. GSM networks were introduced in early to mid-
1990s in Europe and more recently in North America. Earlier,
ﬁrst-generation analogue networks had no or very limited APC
capability (K Hansson Mild, personal communication, 2007), so
phones were nearly always operating at maximum power. Since
the start of GSM systems, improved network coverage may have
reduced power levels, but increased indoor use of phones, more
frequent use of handovers and higher trafﬁc density may have
increased them. Thus, there are uncertainties about backward
extrapolation and we decided, for GSM and other second-
generation networks, to assume a factor of 1 for APC up to its
introduction and of 0.5 afterwards.
For Code Division Multiple Access (CDMA) networks, infor-
mation about power control is scant, except that systems are
very efﬁcient. In a limited number of measurements in Canada,
the average power was 13e15 times less than peak; an APC
factor of 0.067 was therefore chosen for CDMA networks,
compatible with recently published data comparing CDMA and
GSM exposure levels.
41
Inﬂuence of network operator
The SMP study indicated important differences between oper-
ators.
28 Within a frequency band, operator was the most
important factor explaining differences in average power levels
between users. The study, however, was only a snapshot in time
and place, and network optimisation factors vary considerably
over time and place. SMP volunteers moreover did not form
a geographically representative sample of the study population
in most countries, and no information was available for some
networks in study regions. For these reasons, though this adds
uncertainty, the dose algorithm could not include a factor
relating to operator.
Inﬂuence of phone use environment
Urban/rural use
A small (13%e14%) difference in average power levels was
found in the SMP study between subjects using phones mainly
688 Occup Environ Med 2011;68:686e693. doi:10.1136/oemed-2011-100065
Original articlein rural versus urban environments.
28 This was mainly driven by
Sweden, where volunteer selection covered sparsely populated
areas. Few rural users were included in SMP studies elsewhere.
Base-station data from Sweden
36 showed greater urban/rural
differences (factor of 1.6e1.9 depending on time of day), but
data were for 1 week and one operator only.
An urban/rural factor was therefore included in the dose
algorithm only where the study covered a large proportion of the
country (Israel and New Zealand): based on SMP and base-
station studies, average output power was estimated to be 30%
greater in rural users than in urban users for second-generation
phones.
Use while moving or stationary
No difference in average power levels was found in the SMP
study between users using phones mainly while moving in
a vehicle and those reporting mainly stationary use.
28 This was
initially surprising because networks must hand-over a moving
phone from one base-station to another, and with each hand-
over, the power returns to a high level before APC lowers output
to optimum level. Handovers, however, occur frequently in
stationary situations because networks need to distribute trafﬁc
equitably between base-stations, and stationary phone calls may
require extra power in built-up areas because of shielding, thus
explaining the lack of an effect. The SMP study, moreover, may
not have been sufﬁciently sensitive to detect differences:
information available concerned average use (the only informa-
tion collectable in epidemiological studies) rather than use
circumstance of each individual call. Based on the results of the
SMP study, it was decided not to differentiate moving and
stationary use in the dose algorithm.
Indoor/outdoor
A difference was found between output power inside and
outside buildings in a small study.
37 A question was added to the
SMP study, but no difference was found.
28 As no information is
available in the Interphone questionnaire on use inside buildings,
this variable was not included in the algorithm. This decision is
unlikely to bias dose estimates because quality of indoor
communications improved over time, leading to gradual increase
of indoor use from a low level in the earliest years. However, this
is a source of uncertainty.
Inﬂuence of DTX
Use of DTX could not be measured with the SMPs. Data
published in 2000
35 suggest that DTX reduced average power by
about 30% once it was enabled in a network. As little infor-
mation was available from network operators about dates of
DTX enablement and because operators which provided infor-
mation reported it occurred early in GSM networks, it was
assumed all GSM networks in the study were DTX enabled from
1994 to 1995.
Use of phone-speciﬁc SAR values
The dosimetry database of SARmax for phones in use before and
during the Interphone Study included 1233 values. Analysis
showed large variation in SAR, with some SARmax measured
below 0.01 W/kg (current limit of detection) possibly due to
measurement errors. Analyses by time period (online appendix
ﬁgure 3) provided no statistical evidence of a trend over time for
a given communication system. The methods and standards
used to measure SARmax have evolved over time, so SARmax
values are not directly comparable. Analyses (not shown) of
SARmax values for more recent models in the database,
restricted to measurements in reputable laboratories, showed
differences as high as a factor 3 for speciﬁc phone models.
For these reasons and because efﬁciency of phones may
partially compensate or exaggerate differences, phone-speciﬁc
SARmax values were not used in the algorithm: instead, the
Figure 2 Surface and axial views of 1
cm3 SAR (W/kg) distributions in the
GRIDMASTER brain at 800-900 MHz
and 1800 MHz respectively, for a phone
held on the right side (the colour scale
used in all views is the same)
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Original articlemedian of available SARmax measurements was assigned to
phones in a class. For this, SARmax measured with averaging
volumes of 1 or 10 g were converted to the SAR of the 1 cm
3
Gridmaster cell with the highest average SAR for the phone
class. Conversion factors were derived from the database of
SARmax (1 g) and SARmax (10 g) in the French and Japanese
measurements. Single ratios were used for all frequency bands
for SARmax (1 g) and for SARmax (10 g) as analyses showed no
signiﬁcant difference across bands (not shown).
Information on phone use from study subjects
Information on duration and number of calls was reported by
Interphone Study subjects by period of use for each phone they
had used. Information on laterality of use, call environment and
use of hands-free devices was also collected. For time periods for
which a subject reported use of hands-free devices, amount of
use was reduced by 100%, 75%, 50% or 25%, respectively, if
devices were used always or almost always, more than half,
about half or less than half of the time. If the subject reported
a preferred side of use, 90% of use was assigned to that side of
the head and 10% to the other. Otherwise, 50% was assigned to
each side of the head. Sensitivity analyses were also conducted in
which reported laterality was not used at all, and 50% of use
was assigned to each side for all subjects.
Construction of the dose algorithm and application to Interphone
Study subjects
Based on the above, an algorithm was developed for RF dose
from mobile phones in terms of cumulative speciﬁc energy
(CSE) (in joules per kilogram) absorbed at a given location in the
brain (l), for a given frequency band (f) (450, 800e900, 1500,
1800e1900 MHz) and a speciﬁc communication system (s)
(GSM, CDMA, etc). Location can be anywhere within the
Gridmaster cells, and the quantity estimated is the average
within the volume of the relevant cells. The algorithm estimates
the CSE (CSEl,f,s) absorbed at that location for a given study
subject as follows:
CSEl;f;s ¼ +
last
telephone¼1

Xl;c*Averagec

SARx*Conv1=10g

*

+
last
operator¼1
+
last
i¼1
Ti*Hi*Yi;u=r*Pi;f;s;o*Oi;f;s;o

where:
i denotes month of use within a period deﬁned by operator and
phone,
X l,c proportion of the SARmax received at location l, for a phone
in class c
Averagec average over all phones in class c of the argument in
parentheses
SARx SARmax (1 or 10 g) for phone x in class c from the
SARmax measurements of phones.
Conv1/10g conversion factor from SARmax measured for aver-
aging volumes of 1 or 10 g to SARmax in the Gridmaster cell
with highest average SAR.
Ti reported average call time in month i from answers to the
questionnaire
Hi modiﬁer for reported use of hands-free devices in month i
from the questionnaire (see above)
Yi,u/r effect of exposure circumstances modifying output power
(only urban/rural usedsee above)
Pi,f,s o proportion of trafﬁc in frequency f and communication
system s for operator o at time i based on information from
network operators questionnaires. Proportion is 1 if the phone
operated in a single band and system. When dual bands/systems
were enabled, the relative proportions of trafﬁc were taken to
increase linearly from 1.0/0.0 at time of introduction of the
second frequency band/system to p/(1 p)dthe proportions
stated at time of response by the operatordand to remain
constant thereafter.
Oi,f,s,o effect of other modiﬁers as appropriate (APC and DTX,
see above).
The total CSE absorbed at a given location (l)T C S E l for
a particular study subject was obtained by summing over all
combinations of communication systems and frequencies he/she
used. Risk analyses can be conducted both using TCSEl as the
explanatory variable (assuming that carrier frequencies and their
modulation by different communication systems do not modify
possible biological effects) and investigating separately the effect
of CSE in different frequencies and communication systems.
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Based on this algorithm, other metrics can be developed
including the time-weighted average of the absorbed power
(TWA-SAR), obtained by dividing TCSE by total duration of
calls, as well as TCSE and TWA-SAR in different time windows
before case diagnosis to explore the hypotheses that risk, if any,
may be related to dose rate rather than cumulative dose and that
doses in different time windows may have different effects.
Distribution of doses
Table 1 and ﬁgure 3 show the resulting distribution of CSE at
tumour location by communication system and frequency
among glioma study subjects from the ﬁve countries (results for
meningioma study subjects are similardnot shown). Substan-
tial differences were seen between technologies, with CSE being
highest on average for Advanced Mobile Phone System (AMPS)
and lowest for GSM-1800 and CDMA systems.
The distribution of TCSE at the tumour location by cumu-
lative call time, cumulative number of calls and time since start
of use of mobile phones is shown in table 2 overall (see online
appendix table 2 for speciﬁc frequencies and communications
systems).
Table 1 Results of dose estimation for glioma study subjects in ﬁve Interphone countries: estimated TCSE absorbed at the estimated centre of the
tumour in joules per kilogram, by communication system, up to 1 year before reference date
Communication system and frequency
band Number of subjects
TCSE (J/kg)
Mean SD Min Max 25th quartile 75th quartile
AMPSd800 669 5165 24309 0 515471 110 2315
DAMPSd800 507 3946 12921 0 169535 53 1990
GSMd800/900 755 2542 8858 0 89907 57 1279
CDMAd800 262 164 446 0 4355 7 92
GSMd1800 391 467 2325 0 40632 3 187
CDMAd1900 108 185 622 0 5479 4 80
AMPS, Advanced Mobile Phone System; CDMA, Code Division Multiple Access; DAMPS, Digital Advanced Mobile Phone System; GSM, Global System for Mobile.
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risation of subjects by TCSE and cumulative call time (k 0.68),
there is non-negligible misclassiﬁcation: 37%, 21% and 8% of
subjects, respectively, have 1, 2 or more deciles of difference.
Because higher frequencies penetrate less in the brain, the
agreement is substantially lower for GSM-1800 (with 5% having
complete agreement and 86% more than 2 deciles difference)
than for lower frequencies (online appendix table 2). Results are
similar for cumulative number of calls though k statistics, and
agreement are lower. TCSE is also related to time since start of
use (table 2 and online appendix table 2), with most subjects
with high TCSE being long-term users and most short-term
users having low TCSE.
In analysis of variance including the main factors in the dose
algorithm, only cumulative call time and tumour location were
statistically signiﬁcant predictors (predicting, respectively, 43%
and 13% of the variability) for TCSE overall. Results were
similar for analogue systems and 800e900 MHz frequency
bands. For CDMA 1900, APC was statistically signiﬁcantly
associated with CSE (p¼0.015).
DISCUSSION
While attempts to take into account SAR spatial distribution
have been made in epidemiological studies before,
20 43 this is the
ﬁrst attempt to systematically evaluate and quantify the main
parameters thought to inﬂuence RF dose from mobile telephone
use in an epidemiological study.
This work has necessitated identiﬁcation of the likely
important determinants of SAR, and collection of appropriate
information from study subjects, network operators and
laboratories involved in SAR measurements to evaluate the
importance of each factor. It also necessitated the development
of SMPs and the conduct of volunteer studies using these
phones.
The main determinants of TCSE from mobile phones were
found to be communication system and frequency band, tumour
location and amount and duration of mobile phone use. Factors
such as APC (except in CDMA networks where its inﬂuence is
substantial), DTX, urban/rural, moving/stationary and indoor/
outdoor use were found to have a relatively minor inﬂuence.
Although TCSE and cumulative call time agree substantially
in categorising RF exposures, using only the reported call time
creates a complicated mixture of Berkson and classical
measurement errors,
44 particularly at higher frequencies and in
CDMA networks. If RF dose is truly associated with brain
tumour risk, these exposure assessment errors could bias risk
estimates towards the null (no effect) and increase their
Figure 3 Distribution of estimated CSE (in J/kg) at the origin of the
tumour by mobile phone communication system and frequency band.
(Glioma study subjects 5 Interphone countries. For controls, location of
tumour is taken to be the location of the tumour of the case to which
they are matched). AMPS: Advanced Mobile Phone System; D-AMPS:
Digital AMPS; CDMA: code division multiple access; GSM: Global
System for Mobile. Numbers beside CDMA and GSM indicate the main
frequency band (see Appendix 1 for details of the communication
systems).
Table 2 Distribution of deciles of TCSE absorbed at the location of the tumour (in joules per kilogram) by cumulative call time, cumulative number of
calls and time since start of mobile phone use. All frequencies and communication systems. (Glioma study subjects ﬁve Interphone countries)
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136—238.8  0 7 29  28  24  33 8 3 1 0 133 4 10 28 19  21 19 19 11 2 0 133 11 67 51 4 133 
238.9—449.4  0 0 17  26  34  32 27 10 2 0 148 1 1 15 24  31 32 15 20 6 3 148 10 75 51 12 148 
449.5—856.4  0 1 6  9  16  42 22 37 6 1 140 0 2 2 8  30 22 35 21 14 6 140 6 53 74 7 140 
856.5—1069.3  0 0 2  7  19  21 37 36 23 1 146 0 0 3 8  13 28 34 35 13 12 146 0 51 82 13 146 
1609.4—2909.3  0 0 0  1  15  18 25 36 31 8 134 0 0 0 5  12 18 26 27 25 21 134 1 39 75 19 134 
2909.4—8242.7  0 0 0  1  1  6 23 43 41 37 152 0 0 3 1  6 11 19 31 39 42 152 0 33 85 34 152 
8242.8+  0 0 0  0  0  1 4 16 43 105 169 0 0 0 0  1 5 9 19 53 82 169 0 23 95 51 169 
Total  107 118 152 145 157 174 149 183 147 152 1484 105 96 156 132 168 163 176 168 154 166 1484 150 588 596 150 1484 
Weighted 
kappa— statistic   7 3 . 0 9 5 . 0 8 6 . 0 *
% 1 3 . 5 3 % 2 0 . 7 2 % 3 8 . 3 3 t n e m e e r g a %
% 6 8 . 6 3 % 6 0 . 7 3 f f i d e l i c e d 1 %
% 8 6 . 9 1 % 0 5 . 1 2 f f i d e l i c e d 2 %
% 4 4 . 6 1 % 1 6 . 7 f f i d r e t a e r g %
*Combining every two categories of TCSE.
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RF dose would not be detected in caseecontrol and cohort
studies.
44 45 Efforts to take into account main determinants of
dose are therefore important.
There are a number of uncertainties in our estimation of dose,
which will need to be investigated further:
< Uncertainties in spatial SAR distribution for each phone
class,
27 particularly in relation to possible differences within
classes. This study found clustering of phones related to
external phone characteristics only in speciﬁc phone posi-
tions.
31 As this varies during normal use, it cannot be used to
deﬁne phone classes, but regrouping of phones may cause
some misclassiﬁcation.
< Difﬁculties in localising the probable centre of the tumour.
A protocol for localisation was developed and tested by
a panel of neuroradiologists. In most cases, neuroradiologists
reported high conﬁdence in their evaluation. In some
instances, however, particularly when images were not
available for localisation, only tumour location was entered
into the Gridmaster. The centre was then estimated with
a specially developed computer program to ﬁnd the tumour’s
centre of gravity (except for meningioma located at the
surface of the meninges, close to the skull, for which the
centre was estimated as the geometric centre of gravity of the
outermost layer of the tumour). Comparison of centres
predicted in this way with tumour centres estimated by
neuroradiologist showed good agreement.
46
< Lack of reliable systematic information on SARmax and
phone efﬁciency for speciﬁc phones used by study subjects
and lack of information on parameters inﬂuencing APC for
speciﬁc networks in the study. Average information therefore
had to be used, adding uncertainty to the dose estimation.
< Potential error in recall of phone use: Interphone validation
studies indicated that recall was subject to moderate
systematic but substantial random error.
47 Systematic errors
were larger for duration of calls than number of calls, and
phone use was underestimated by light users and over-
estimated by heavy users. There was little evidence overall
that error was different between cases and controls overall,
though cases appeared to over-report for more distant time
periods.
48
< Potential error in laterality of use. Little direct data exist on
laterality recall errors, and impact of potential recall biases on
risk estimates has been the topic of debate.
21 Since laterality
is one of the components of our algorithm, risk estimates can
be derived with or without it, thereby shedding some light on
this important question.
< Pulsed low-frequency magnetic ﬁelds from digital phones. DC
electricity ﬂowing from the phone’s battery with each pulsed
data transmission generates magnetic ﬁelds
49 50 (online
appendix ﬁgure 4). For GSM phones, these 217 Hz pulses
have frequency components in the extremely low-frequency
range, where brain cancer risks have been inconsistently
associated with occupational exposures.
51 Interphone inves-
tigated the feasibility of estimating exposure to pulsed
magnetic ﬁeld emissions, but this was beyond the study’s
resources. Pilot measurements made on SMPs (online
appendix 2) demonstrated that CSE and cumulative
exposures to pulsed magnetic ﬁelds have many of the same
determinants (online appendix ﬁgures 4e5). Therefore, the
cumulative magnitude of pulsed magnetic ﬁelds from digital
mobile phones may be confounded with TCSE in
epidemiological studies.
< Lack of knowledge regarding the biologically relevant dose
metric. Although correct speciﬁcation of dose metric can have
a major impact on a study’s power,
52 laboratory studies of
effects of non-thermal RF exposures provide little guidance
on biophysical mechanisms, if any, and relevant dose metric
for RF epidemiology. Cumulative dose is a biologically valid
dose measure for many carcinogenic agents, such as ionising
radiation, and was therefore used as the main metric in our
study, though other metrics such as dose rate and cumulative
electric ﬁeld strength can also be derived from our algorithm.
CONCLUSIONS
While substantial agreement was found between categorisation
of subjects by TCSE and cumulative call time, there was non-
negligible misclassiﬁcation, related to communication system
and tumour location, particularly at higher frequency bands.
While this is important for Interphone, it will be particularly
important in future epidemiological studies in which a greater
proportion of subjects will have used higher 1500, 1800e1900,
2200 MHz frequency bands and communication systems with
more efﬁcient power control like CDMA and UMTS. Efforts to
investigate different dose metrics and to quantify the uncer-
tainties described above in future, more detailed studies are
needed to improve dose estimation and reduce uncertainty in
caseecontrol and cohort studies of brain tumours and RF
exposure from mobile telephones.
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